Donations will be given to the OHSU Knight Cancer Institute.
Researchers at the Knight Cancer Institute have built a groundbreaking clinical trial platform called SMMART, which uses a combination of targeted drugs to stop tumors before they can adapt and become drug-resistant. Currently, the team is focusing on metastatic breast cancer—and so far, results have exceeded expectations.
